ClinicalTrials.govpublic full text
ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
infection, human immunodeficiency virus, hiv infections, arthralgia, dolutegravir/abacavir/lamivudine fixed dose combination, pregnant women, once daily, antiretroviral therapy-naive, hiv-1 infection, integrase inhibitor, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 905895
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.